Hereditary Leiomyomatosis And Renal Cell Cancer

What Hereditary Leiomyomatosis and Renal Cell Cancer Means in Everyday Language

Hereditary leiomyomatosis and renal cell cancer, often called HLRCC, is a rare inherited condition caused by changes in a gene called FH (fumarate hydratase). This gene helps cells produce energy properly. When it doesn’t work right, it can lead to growths in the body. People with HLRCC develop non-cancerous tumors called leiomyomas, which grow in the smooth muscle tissue of the skin and uterus. These skin tumors usually appear as small, firm bumps on the arms, legs, chest, or abdomen. Women with HLRCC often have uterine fibroids that are larger and appear earlier than usual. Importantly, people with this condition also have an increased risk of developing a certain type of kidney cancer, called papillary type 2 renal cell carcinoma, which tends to occur earlier in life than typical kidney cancers.

Why HLRCC Matters in Cancer Care

HLRCC is important because it raises the risk of kidney cancer, which can be aggressive and may appear at a younger age than usual. Recognizing the condition early allows doctors to monitor for kidney tumors closely and manage skin and uterine growths. Because HLRCC is inherited in an autosomal dominant way, it means that family members may also carry the gene change and have similar risks. Genetic counseling and testing can help identify who may be affected, guiding screening and care to catch problems early.

What Patients Might See, Feel, or Be Told

If you have HLRCC, you might notice small, firm bumps on your skin that can be painful, especially when touched or exposed to cold. Women may experience uterine fibroids that cause symptoms like heavy periods or pelvic pain. Kidney cancer related to HLRCC often does not cause symptoms early on, so regular monitoring is important. If your medical records mention HLRCC or the FH gene mutation, it’s helpful to ask your care team what this means for your health and what steps to take next.

Common Sources of Confusion and Related Terms

The term "leiomyoma" refers to benign (non-cancerous) tumors made of smooth muscle, which can appear in the skin or uterus. These are different from cancer but may signal the inherited condition HLRCC. The FH gene is sometimes called fumarate hydratase or fumarase gene; these all refer to the same gene involved in energy production in cells. Seeing these terms in reports does not mean cancer is present but may indicate a risk that needs further evaluation. HLRCC is also known as Reed’s syndrome and is related to other inherited cancer syndromes but is distinct in its features and risks.

How to Use This Information and Next Steps

If you learn that you or a family member has HLRCC or an FH gene mutation, the best step is to talk with your healthcare team or a genetic counselor. They can explain what this means for your health, discuss genetic testing for family members, and recommend monitoring plans to watch for kidney cancer and manage skin or uterine tumors. This information helps you and your care team make informed decisions about your health. Remember, this entry is for education and does not replace personalized medical advice. Always ask your care team about what these terms mean for your specific situation.